関連する実験動画
Updated: May 11, 2026
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
膵臓がんにおけるS-ニトロシル化関連LAMC2を重要な予後ドライバーとして特定する単一細胞トランスクリプトームプロファイリングと機械学習
Chenchen Yang1, Hengfa Ge1, Yunfan Yin2
1Department of Emergency Medicine, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, 223300, Jiangsu, China.
Background:
Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide, characterized by late diagnosis, limited therapeutic options, and dismal prognosis. Post-translational modifications (PTMs) are increasingly recognized as key regulators of tumor biology, yet the role of S-nitrosylation-a redox-based cysteine modification-has not been systematically investigated in PC.
Methods:
We integrated bulk and single-cell transcriptomic data from TCGA, ICGC, and GEO cohorts to comprehensively profile S-nitrosylation-related gene expression. A large-scale machine-learning framework incorporating 101 algorithmic combinations was used to construct an optimized prognostic model. Kaplan-Meier, ROC, and PCA analyses evaluated predictive power and stability across nine independent cohorts. The key hub gene LAMC2 was identified and subjected to single-gene bioinformatic analysis and functional validation through in-vitro experiments using MIA-PaCa-2 cells.
Results:
S-nitrosylation exhibited the highest enrichment among all PTM types in pancreatic cancer and was mainly localized to malignant ductal and fibroblast cells. The StepCox(backward) + GBM model showed excellent prognostic performance (TCGA C-index = 0.827) and successfully stratified patients into high- and low-risk groups across multiple external datasets. High-risk patients displayed distinct transcriptional profiles and significantly worse survival outcomes (all p < 0.01). Among S-nitrosylation-related genes, LAMC2 showed the strongest correlation with risk score (r = 0.63) and was consistently upregulated in tumors. Cox and GSEA analyses linked LAMC2 to epithelial-mesenchymal transition, TGF-β, and hypoxia pathways. Functionally, LAMC2 knockdown suppressed migration and colony formation in pancreatic cancer cells.
Conclusions:
This study establishes S-nitrosylation as a crucial PTM in pancreatic cancer and introduces a robust machine-learning-based prognostic model. LAMC2 is identified as a key oncogenic effector connecting S-nitrosylation dysregulation to tumor aggressiveness, providing novel prognostic and therapeutic insights for pancreatic cancer management.
